Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 12, 2008, Pages 1685-1692

  Tran, Thi Ha Chau ^a,b   Fardeau, Christine ^a   Terrada, Céline ^a   Ducos De Lahitte, Ghislaine ^a   Bodaghi, Bahram ^a   Lehoang, Phuc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Bevacizumab; Choroidal neovascularization; Intravitreal injections; Uveitis

Indexed keywords

AZATHIOPRINE; BEVACIZUMAB; METHOTREXATE; METHYLPREDNISOLONE; PEGAPTANIB; PREDNISONE; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DISEASE; SHORT COURSE THERAPY; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DIABETIC RETINOPATHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULA LUTEA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY; VITREOUS HEMORRHAGE; YOUNG ADULT;

EID: 56049105860     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0906-4     Document Type: Article

References (30)

1. Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye 12(Pt 2):266-272
2. Hogan A, Behan U, Kilmartin DJ (2005) Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br J Ophthalmol 89:1109-1111, doi: 10.1136/ bjo.2004.063024
3. Thorne JE, Wittenberg S, Jabs DA, Peters GB, Reed TL, Kedhar SR et al (2006) Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology 113:2310-2316, doi: 10.1016/j.ophtha.2006.05.067
4. Giovannini A, Neri P, Mercanti L, Brue C (2007) Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation. Br J Ophthalmol 91:620-623, doi: 10.1136/bjo.2006.103135
5. Leslie T, Lois N, Christopoulou D, Olson JA, Forrester JV (2005) Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 89:147-150, doi: 10.1136/bjo.2004.046623
6. Nowilaty SR, Bouhaimed M (2006) Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 90:982-986, doi: 10.1136/bjo.2006.091538
7. Parodi MB, Iacono P, Spasse S, Ravalico G (2006) Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol 141:123-128, doi: 10.1016/j.ajo.2005.07.045
8. Brown DM, Regillo CD (2007) Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 144:627-637, doi: 10.1016/j.ajo.2007.06.039
9. Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT et al (2007) Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 27:439-444, doi: 10.1097/ IAE.0b013e31804b3e15
10. Hernandez-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solis-Vivanco A et al (2007) Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina 27:707-712
11. Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C (2007) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125:1422-1423, doi: 10.1001/archopht.125.10.1422
12. Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A (2007) Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization. Arch Ophthalmol 125:1487-1492, doi: 10.1001/ archopht.125.11.1487
13. Gomi F, Nishida K, Oshima Y, Sakaguchi H, Sawa M, Tsujikawa M et al (2007) Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone. Am J Ophthalmol 143:507-510, doi: 10.1016/ j.ajo.2006.10.050
14. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143:977-983, doi: 10.1016/ j.ajo.2007.02.039
15. Adan A, Mateo C, Navarro R, Bitrian E, Casaroli-Marano RP (2007) Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina 27:1180-1186
16. Macular Photocoagulation Study Group (1987) Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 105:1499-1507
17. Morgan CM, Schatz H (1986) Recurrent multifocal choroiditis. Ophthalmology 93:1138-1147
18. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647-652, doi: 10.1016/S0002-9394(01)00925-4
19. Lim WK, Buggage RR, Nussenblatt RB (2005) Serpiginous choroiditis. Surv Ophthalmol 50:231-244, doi: 10.1016/j.survophthal.2005.02.010
20. Dees C, Arnold JJ, Forrester JV, Dick AD (1998) Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol 116:1456-1461
21. Fine SL, Wood WJ, Isernhagen RD, Singerman LJ, Bressler NM, Folk JC et al (1993) Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: Results of a pilot randomized clinical trial. Arch Ophthalmol 111:19-20
22. Essex RW, Tufail A, Bunce C, Aylward GW (2007) Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration. Br J Ophthalmol 91:649-654, doi: 10.1136/bjo.2005.089458
23. Rogers AH, Duker JS, Nichols N, Baker BJ (2003) Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 110:1315-1320, doi: 10.1016/S0161-6420(03)00466-4
24. Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y (2002) Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 22:545-549, doi: 10.1097/00006982-200210000-00003
25. Borkowski LM, Weinberg DV, Delany CM, Milsow L (2001) Laser photocoagulation for choroidal neovascularization associated with sympathetic ophthalmia. Am J Ophthalmol 132:585-587, doi: 10.1016/ S0002-9394(01)01044-3
26. Bom S, Young S, Gregor Z, Lightman S (2002) Surgery for choroidal neovascularization in sympathetic opthalmia. Retina 22:109-111, doi: 10.1097/00006982-200202000-00021
27. Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS (2008) Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: One-year results of a prospective series. Retina 28:71-80
28. Farah ME, Costa RA, Muccioli C, Guia TA, Belfort R (2002) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 134:137-139, doi: 10.1016/ S0002-9394(02)01456-3
29. Kinge B, Syrdalen P, Bjornsson OM (2005) Photodynamic therapy for choroidal neovascularization secondary to sympathetic ophthalmia. Retina 25:375-377, doi: 10.1097/00006982-200504000-00023
30. Kuo IC, Rechdouni A, Rao NA, Johnston RH, Margolis TP, Cunningham ET (2000) Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology 107:1721-1728, doi: 10.1016/S0161-6420(00)00244-X